Xavier ROBLIN
Centre Hospitalier Universitaire de Saint Etienne · CHU de SAINT-ETIENNE
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Xavier ROBLIN as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:18 UTC. Open this list on ClinicalTrials.gov
- N/ANCT04030676 · QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative ColitisCentre Hospitalier Universitaire de Saint Etienne · recruiting · Cytomegalovirus Infections · principal investigator
- N/ANCT03724929 · Value of Pharmacokinetic Assays in the Prediction of Therapeutic Response in Ulcerative ColitisCentre Hospitalier Universitaire de Saint Etienne · terminated · Ulcerative Colitis · principal investigator
- Ph2NCT03182166 · Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose OptimizationCentre Hospitalier Universitaire de Saint Etienne · completed · Ulcerative Colitis · principal investigator
- N/ANCT03172195 · Detection of Herpesvirus DNA (CMV, EBV, HHV-6 and HSV) in Colonic Tissue: Impact on Ulcerative Colitis Flare-upCentre Hospitalier Universitaire de Saint Etienne · terminated · Colitis, Ulcerative · principal investigator
- Ph4NCT02768532 · Value of Pharmacokinetic Assays in the Prediction of Induction and Maintenance Therapeutic Response in Crohn's DiseaseCentre Hospitalier Universitaire de Saint Etienne · terminated · Crohn Disease · principal investigator
- N/ANCT02502552 · Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD CohortCentre Hospitalier Universitaire de Saint Etienne · completed · Crohn's Disease, Ulcerative Colitis, Inflammatory Bowel Disease · principal investigator
- N/ANCT02367326 · Identification of Scores Associated With a Favorable Clinical Response With Thiopurines in IBD PatientsCentre Hospitalier Universitaire de Saint Etienne · completed · Inflammatory Bowel Diseases · principal investigator
- Ph2NCT02255227 · Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBDCentre Hospitalier Universitaire de Saint Etienne · terminated · Infections, Pneumococcal, Bowel Diseases, Inflammatory · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:18 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:18 UTC. The ranking covers the 200 most relevant of 27 PubMed records, and a shared surname and initials can bring in a namesake. All 27 on PubMed
- 506 citationsRCR 18.2
- 371 citationsRCR 13.5
- 135 citationsRCR 7.1
- 114 citationsRCR 5.9
- Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial.Aliment Pharmacol Ther · 2017109 citationsRCR 5.2
- 109 citationsRCR 6.3
- Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis.Gastroenterology · 2016108 citationsRCR 4.9
- Adalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: an open-label study.World J Gastroenterol · 200775 citationsRCR 2.3
- Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single-centre experience.Aliment Pharmacol Ther · 200871 citationsRCR 2.2
- Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial.Clin Gastroenterol Hepatol · 202048 citationsRCR 3.4